跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 17, 2021
Approval ID
28240b8d1fd2e22e
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
28240b8d1fd2e22e
Drug Cima Aemps Name
CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
114957001IP
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Authorization Date
2021-05-17
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
10 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
RAMUCIRUMAB
10 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 17, 2021
Approval ID
28240b8d1fd2e22e
Type
Standard
Back to CIMA-AEMPS Approvals